Advagraf 3 mg (Tacrolimus CAPSULE (EXTENDED RELEASE)) 3 MG

ADVAGRAF 3 MG capsules are an extended-release formulation of tacrolimus, used to prevent organ rejection post-transplant. This immunosuppressant helps maintain transplant success by reducing immune system activity.

Strength

3 MG

Pack Size

Manufacturer / TM Owner

ASTELLAS PHARMA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADVAGRAF 3 MG capsules are primarily used to prevent organ rejection in patients who have undergone liver or kidney transplants. Tacrolimus works by suppressing the immune system, allowing the body to accept the transplanted organ. This medication is often prescribed as part of a broader treatment plan to ensure the success of the transplant procedure.

Side Effects

Common effects of ADVAGRAF 3 MG may include tremors, headaches, and gastrointestinal issues such as nausea or diarrhea. Some individuals might experience changes in kidney function or blood pressure. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

Precautions & Warnings

ADVAGRAF 3 MG should be handled with care, as it is an immunosuppressant. Patients should avoid activities that increase the risk of infection and follow a balanced diet to support overall health. Regular blood tests may be required to monitor kidney function and drug levels in the blood.

Avoid Interactions

ADVAGRAF 3 MG may interact with various medications, including certain antibiotics, antifungals, and anticonvulsants. Grapefruit and grapefruit juice should be avoided, as they can affect how the body processes tacrolimus. Always inform healthcare providers about all medications being taken to avoid potential interactions.

Frequently Asked Questions

ADVAGRAF 3 MG is used to prevent organ rejection in patients who have undergone liver or kidney transplants.

ADVAGRAF 3 MG capsules should be taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include tremors, headaches, nausea, diarrhea, and changes in kidney function.

ADVAGRAF 3 MG may interact with certain medications, so it's important to consult a healthcare provider before combining it with other drugs.

Long-term use of ADVAGRAF 3 MG should be monitored by a healthcare provider to manage potential side effects and ensure its continued effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.